⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCS News
Oculis Holding AG Ordinary shares
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
globenewswire.com
OCS
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
globenewswire.com
OCS
Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors
globenewswire.com
OCS
Oculis Publishes Results of 2026 Annual General Meeting and Announces Election of Gregory D. Perry to its Board of Directors
globenewswire.com
OCS
Oculis Reports Q1 2026 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Reports Q1 2026 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
globenewswire.com
OCS
Oculis Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Optic Neuritis Registrational Trial
globenewswire.com
OCS
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
globenewswire.com
OCS
Latest Findings from DME AWARE Delphi Study Presented at ARVO 2026 Annual Meeting
globenewswire.com
OCS